![](/img/cover-not-exists.png)
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Janni, Wolfgang, Alba, Emilio, Bachelot, Thomas, Diab, Sami, Gil-Gil, Miguel, Beck, Thaddeus J., Ryvo, Larisa, Lopez, Rafael, Tsai, Michaela, Esteva, Francisco J., Auñón, Pilar Zamora, Kral, Zdenek, WLanguage:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-017-4658-x
Date:
February, 2018
File:
PDF, 2.18 MB
english, 2018